Exubera hmm… not good
April 10, 2008
This article was sent to me by my fellow blogger, Ben who suggested that this might be an interesting article for readers. Seems so:
Pfizer Inc and said on Wednesday clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to stop seeking a marketing partner for the troubled product and abandon it.
I had hopes for Exubera. Did you?
